Report Detail

Pharma & Healthcare Global Medicated Chewing Gums Market Research Report 2022

  • RnM4457720
  • |
  • 22 June, 2022
  • |
  • Global
  • |
  • 90 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Industry Insights
Due to the COVID-19 pandemic, the global Medicated Chewing Gums market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Medicated Chewing Gums market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Medicated Chewing Gums landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Solid accounting for % of the Medicated Chewing Gums global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Nursing Homes segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Medicated Chewing Gums include Rugby, Nicorette, Enorama, Skyepharma, FIA, Dimenhydrinate, Fertin Pharma, Skyepharma Production SAS and Alkalon, etc. In terms of revenue, the global 3 largest players have a % market share of Medicated Chewing Gums in 2021.

This report focuses on Medicated Chewing Gums volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Medicated Chewing Gums market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Medicated Chewing Gums market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Solid

Semi-solid

Segment by Application

Nursing Homes

Hospitals

Smoking Cessation Center

Home

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Rugby

Nicorette

Enorama

Skyepharma

FIA

Dimenhydrinate

Fertin Pharma

Skyepharma Production SAS

Alkalon

ENORAMA PHARMA AB

Mastix

Agro Gums

Perfetti Van Melle

WM

Frequently Asked Questions

Which product segment grabbed the largest share in the Medicated Chewing Gums market?

How is the competitive scenario of the Medicated Chewing Gums market?

Which are the key factors aiding the Medicated Chewing Gums market growth?

Which are the prominent players in the Medicated Chewing Gums market?

Which region holds the maximum share in the Medicated Chewing Gums market?

What will be the CAGR of the Medicated Chewing Gums market during the forecast period?

Which application segment emerged as the leading segment in the Medicated Chewing Gums market?

What key trends are likely to emerge in the Medicated Chewing Gums market in the coming years?

What will be the Medicated Chewing Gums market size by 2028?

Which company held the largest share in the Medicated Chewing Gums market?


1 Medicated Chewing Gums Market Overview

  • 1.1 Product Overview and Scope of Medicated Chewing Gums
  • 1.2 Medicated Chewing Gums Segment by Type
  • 1.2.1 Global Medicated Chewing Gums Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 Solid
  • 1.2.3 Semi-solid
  • 1.3 Medicated Chewing Gums Segment by Application
  • 1.3.1 Global Medicated Chewing Gums Sales Comparison by Application: (2022-2028)
  • 1.3.2 Nursing Homes
  • 1.3.3 Hospitals
  • 1.3.4 Smoking Cessation Center
  • 1.3.5 Home
  • 1.3.6 Others
  • 1.4 Global Medicated Chewing Gums Market Size Estimates and Forecasts
  • 1.4.1 Global Medicated Chewing Gums Revenue 2017-2028
  • 1.4.2 Global Medicated Chewing Gums Sales 2017-2028
  • 1.4.3 Medicated Chewing Gums Market Size by Region: 2017 Versus 2021 Versus 2028
  • 2 Medicated Chewing Gums Market Competition by Manufacturers

    • 2.1 Global Medicated Chewing Gums Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Medicated Chewing Gums Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Medicated Chewing Gums Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Medicated Chewing Gums Manufacturing Sites, Area Served, Product Type
    • 2.5 Medicated Chewing Gums Market Competitive Situation and Trends
    • 2.5.1 Medicated Chewing Gums Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Medicated Chewing Gums Players Market Share by Revenue
  • 2.5.3 Global Medicated Chewing Gums Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 3 Medicated Chewing Gums Retrospective Market Scenario by Region

    • 3.1 Global Medicated Chewing Gums Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Medicated Chewing Gums Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Medicated Chewing Gums Market Facts & Figures by Country
    • 3.3.1 North America Medicated Chewing Gums Sales by Country
  • 3.3.2 North America Medicated Chewing Gums Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
  • 3.4 Europe Medicated Chewing Gums Market Facts & Figures by Country
  • 3.4.1 Europe Medicated Chewing Gums Sales by Country
  • 3.4.2 Europe Medicated Chewing Gums Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
  • 3.5 Asia Pacific Medicated Chewing Gums Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Medicated Chewing Gums Sales by Region
  • 3.5.2 Asia Pacific Medicated Chewing Gums Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.6 Latin America Medicated Chewing Gums Market Facts & Figures by Country
  • 3.6.1 Latin America Medicated Chewing Gums Sales by Country
  • 3.6.2 Latin America Medicated Chewing Gums Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.7 Middle East and Africa Medicated Chewing Gums Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Medicated Chewing Gums Sales by Country
  • 3.7.2 Middle East and Africa Medicated Chewing Gums Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE
  • 4 Global Medicated Chewing Gums Historic Market Analysis by Type

    • 4.1 Global Medicated Chewing Gums Sales Market Share by Type (2017-2022)
    • 4.2 Global Medicated Chewing Gums Revenue Market Share by Type (2017-2022)
    • 4.3 Global Medicated Chewing Gums Price by Type (2017-2022)

    5 Global Medicated Chewing Gums Historic Market Analysis by Application

    • 5.1 Global Medicated Chewing Gums Sales Market Share by Application (2017-2022)
    • 5.2 Global Medicated Chewing Gums Revenue Market Share by Application (2017-2022)
    • 5.3 Global Medicated Chewing Gums Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Rugby
    • 6.1.1 Rugby Corporation Information
  • 6.1.2 Rugby Description and Business Overview
  • 6.1.3 Rugby Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 Rugby Medicated Chewing Gums Product Portfolio
  • 6.1.5 Rugby Recent Developments/Updates
  • 6.2 Nicorette
  • 6.2.1 Nicorette Corporation Information
  • 6.2.2 Nicorette Description and Business Overview
  • 6.2.3 Nicorette Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 Nicorette Medicated Chewing Gums Product Portfolio
  • 6.2.5 Nicorette Recent Developments/Updates
  • 6.3 Enorama
  • 6.3.1 Enorama Corporation Information
  • 6.3.2 Enorama Description and Business Overview
  • 6.3.3 Enorama Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 Enorama Medicated Chewing Gums Product Portfolio
  • 6.3.5 Enorama Recent Developments/Updates
  • 6.4 Skyepharma
  • 6.4.1 Skyepharma Corporation Information
  • 6.4.2 Skyepharma Description and Business Overview
  • 6.4.3 Skyepharma Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Skyepharma Medicated Chewing Gums Product Portfolio
  • 6.4.5 Skyepharma Recent Developments/Updates
  • 6.5 FIA
  • 6.5.1 FIA Corporation Information
  • 6.5.2 FIA Description and Business Overview
  • 6.5.3 FIA Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 FIA Medicated Chewing Gums Product Portfolio
  • 6.5.5 FIA Recent Developments/Updates
  • 6.6 Dimenhydrinate
  • 6.6.1 Dimenhydrinate Corporation Information
  • 6.6.2 Dimenhydrinate Description and Business Overview
  • 6.6.3 Dimenhydrinate Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 Dimenhydrinate Medicated Chewing Gums Product Portfolio
  • 6.6.5 Dimenhydrinate Recent Developments/Updates
  • 6.7 Fertin Pharma
  • 6.6.1 Fertin Pharma Corporation Information
  • 6.6.2 Fertin Pharma Description and Business Overview
  • 6.6.3 Fertin Pharma Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Fertin Pharma Medicated Chewing Gums Product Portfolio
  • 6.7.5 Fertin Pharma Recent Developments/Updates
  • 6.8 Skyepharma Production SAS
  • 6.8.1 Skyepharma Production SAS Corporation Information
  • 6.8.2 Skyepharma Production SAS Description and Business Overview
  • 6.8.3 Skyepharma Production SAS Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 Skyepharma Production SAS Medicated Chewing Gums Product Portfolio
  • 6.8.5 Skyepharma Production SAS Recent Developments/Updates
  • 6.9 Alkalon
  • 6.9.1 Alkalon Corporation Information
  • 6.9.2 Alkalon Description and Business Overview
  • 6.9.3 Alkalon Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 Alkalon Medicated Chewing Gums Product Portfolio
  • 6.9.5 Alkalon Recent Developments/Updates
  • 6.10 ENORAMA PHARMA AB
  • 6.10.1 ENORAMA PHARMA AB Corporation Information
  • 6.10.2 ENORAMA PHARMA AB Description and Business Overview
  • 6.10.3 ENORAMA PHARMA AB Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.10.4 ENORAMA PHARMA AB Medicated Chewing Gums Product Portfolio
  • 6.10.5 ENORAMA PHARMA AB Recent Developments/Updates
  • 6.11 Mastix
  • 6.11.1 Mastix Corporation Information
  • 6.11.2 Mastix Medicated Chewing Gums Description and Business Overview
  • 6.11.3 Mastix Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.11.4 Mastix Medicated Chewing Gums Product Portfolio
  • 6.11.5 Mastix Recent Developments/Updates
  • 6.12 Agro Gums
  • 6.12.1 Agro Gums Corporation Information
  • 6.12.2 Agro Gums Medicated Chewing Gums Description and Business Overview
  • 6.12.3 Agro Gums Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.12.4 Agro Gums Medicated Chewing Gums Product Portfolio
  • 6.12.5 Agro Gums Recent Developments/Updates
  • 6.13 Perfetti Van Melle
  • 6.13.1 Perfetti Van Melle Corporation Information
  • 6.13.2 Perfetti Van Melle Medicated Chewing Gums Description and Business Overview
  • 6.13.3 Perfetti Van Melle Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.13.4 Perfetti Van Melle Medicated Chewing Gums Product Portfolio
  • 6.13.5 Perfetti Van Melle Recent Developments/Updates
  • 6.14 WM
  • 6.14.1 WM Corporation Information
  • 6.14.2 WM Medicated Chewing Gums Description and Business Overview
  • 6.14.3 WM Medicated Chewing Gums Sales, Revenue and Gross Margin (2017-2022)
  • 6.14.4 WM Medicated Chewing Gums Product Portfolio
  • 6.14.5 WM Recent Developments/Updates
  • 7 Medicated Chewing Gums Manufacturing Cost Analysis

    • 7.1 Medicated Chewing Gums Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Medicated Chewing Gums
  • 7.4 Medicated Chewing Gums Industrial Chain Analysis
  • 8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Medicated Chewing Gums Distributors List
    • 8.3 Medicated Chewing Gums Customers

    9 Medicated Chewing Gums Market Dynamics

    • 9.1 Medicated Chewing Gums Industry Trends
    • 9.2 Medicated Chewing Gums Market Drivers
    • 9.3 Medicated Chewing Gums Market Challenges
    • 9.4 Medicated Chewing Gums Market Restraints

    10 Global Market Forecast

    • 10.1 Medicated Chewing Gums Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Medicated Chewing Gums by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Medicated Chewing Gums by Type (2023-2028)
  • 10.2 Medicated Chewing Gums Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Medicated Chewing Gums by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Medicated Chewing Gums by Application (2023-2028)
  • 10.3 Medicated Chewing Gums Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Medicated Chewing Gums by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Medicated Chewing Gums by Region (2023-2028)
  • 11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
    • 12.3 Author List
    • Summary:
      Get latest Market Research Reports on Medicated Chewing Gums. Industry analysis & Market Report on Medicated Chewing Gums is a syndicated market report, published as Global Medicated Chewing Gums Market Research Report 2022. It is complete Research Study and Industry Analysis of Medicated Chewing Gums market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,375.10
      4,750.20
      2,752.10
      5,504.20
      394,371.00
      788,742.00
      228,520.00
      457,040.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report